An interventional study of Suit therapy and Suit therapy + Dual-task exercises in Suit Therapy, Dual Task Exercises and Gross Motor Functions, sponsored by Kafrelsheikh University. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-07-31.
Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Cerebral Palsy by Kafrelsheikh University — 9 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · Kafrelsheikh University.
Among the 12 studies in Cerebral Palsy by Kafrelsheikh University, this one is the 8th largest by planned enrollment, is the only one that started in 2023, is one of 12 with no phase, and was the 11th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →9 of the 12 studies in Cerebral Palsy by Kafrelsheikh University are open now, in 1 country. Recruiting first, the newest first:
Kafrelsheikh University · Sites in Egypt
Ages 2–6
Kafrelsheikh University · Sites in Egypt
Ages 6–10 · Healthy volunteers
Kafrelsheikh University · Sites in Egypt
Ages 5–10
Kafrelsheikh University · Sites in Egypt
Ages 3–14
Kafrelsheikh University · Sites in Egypt
Ages 3–7
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 6 Years to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2023; this study’s year is marked. 1 started in 2023.
This study's planned enrollment of 30 is below the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 36 across the 12 interventional studies. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Kafrelsheikh University is the lead sponsor of 305 studies on the registry; 122 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Cerebral Palsy by Kafrelsheikh University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the effect of suit therapy combined with dual-task training on gross motor performance and walking abilities in children with diplegic cerebral palsy.
Cerebral palsy (CP) is a non-progressive motor impairment syndrome caused by brain defects or lesions that occur in an immature brain before, during, or within two years after birth.
Therapeutic approaches for CP include neurodevelopmental treatment, Vojta therapy, sensory integration therapy, and conductive education. Specific therapeutic strategies for CP may differ, but they all aim to improve the independence of children with CP.
Suit therapy is a relatively new and experimental form of therapy designed to help those with cerebral palsy improve muscle tone, posture, and movements.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will receive suit therapy.
Other: Suit therapy
Patients will receive suit therapy in addition to dual-task exercises.
Other: Suit therapy + Dual-task exercises
Patients will receive suit therapy.
Patients will receive suit therapy in addition to dual-task exercises.
Evaluation of Gross Motor Function Measure 88 (GMFM-88)
The Gross Motor Function Measure (GMFM) 88 will be used to determine the severity of each case and to assess the child's motor performance in five dimensions: lying and rolling (17 items); sitting (20 items); crawling and kneeling (14 items); standing (13 items); and walking, running, and jumping (24 items). All items will be checked and scored before interpretation of the child's performance in each dimension. Scores of each dimension will be expressed as a percentage of the maximum scores for that dimension. The total score will be obtained by averaging the percentage scores across the five dimensions. Individual dimensions of GMFM-88 can be administered depending on the child's current level of function.
Time frame: 3 months post-exercise
Evaluation of balance using the Pediatric Balance Scale (PBS)
The Pediatric Balance Scale (PBS) is a standardized tool for testing balance. The items can be measured within 15 minutes and do not require specialized equipment. The Pediatric Balance Scale is a modified version of the Berg Balance Scale, used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function), with a maximum score of 56 points
Time frame: 3 months post-exercise
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Sep 2025, 23 months after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 23 months is above that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.